StimCytes™ CD19 are precision engineered synthetic cell mimics designed to support CAR‑T potency assessment through targeted CD19 specific activation, cytokine release and biomarker driven assay development. Each kit enables baseline, enhanced and negative activation profiles of CD19 directed CAR‑T cells during antigen engagement.
Unlike cell controls, StimCytes™CD19 provides consistent antigen expression and reproducible activation characteristics that remove the variability associated with donor derived materials. These lyophilized synthetic cells feature selected biomarkers that support stable potency evaluation and streamlined assay optimization across experiments and platforms. The kit includes a high activation mimic with enhancers, a baseline activation mimic and a non activating negative control to establish clear functional benchmarks.
StimCytes™CD19 are intended for research use only and are not suitable for diagnostic or therapeutic procedures. These products are safe to use in any environment, contain no biohazardous material and require no special disposal. (FKA: TruCytes™ Potency BCMA)
| Specification | Value |
|---|---|
| Format | Lyophilized synthetic cell mimics; kit includes high activation mimic (with enhancers), baseline activation mimic, and non-activating negative control |
| Available Sizes | 1 kit (default) |
| Target Antigen | CD19 |
| Application | CAR-T potency assessment, cytokine release assays, biomarker-driven assay development |
| Activation Profiles | Baseline activation, enhanced activation, and negative (non-activating) control |
| Instrument Compatibility | Compatible across multiple analytical platforms |
| Handling & Safety | No biohazardous material; no special handling, disposal, or safety precautions required |
| Intended Use | Research use only — not for diagnostic or therapeutic procedures |
| Manufacturer | Slingshot Biosciences |
StimCytes™ CD19 are precision engineered synthetic cell mimics designed to support CAR‑T potency assessment through targeted CD19 specific activation, cytokine release and biomarker driven assay development. Each kit enables baseline, enhanced and negative activation profiles of CD19 directed CAR‑T cells during antigen engagement. Unlike cell controls, StimCytes™CD19 provides consistent antigen expression and reproducible activation characteristics that remove the variability associated with donor derived materials. These lyophilized synthetic cells feature selected biomarkers that support stable potency evaluation and streamlined assay optimization across experiments and platforms. The kit includes a high activation mimic with enhancers, a baseline activation mimic and a non activating negative control to establish clear functional benchmarks. StimCytes™CD19 are intended for research use only and are not suitable for diagnostic or therapeutic procedures. These products are safe to use in any environment, contain no biohazardous material and require no special disposal. (FKA: TruCytes™ Potency BCMA) More information: Poster:Cell Mimics as High Precision Controls For CGT Analytics and Potency Assays Application Note:Cell Mimics as a Robust Quality Control Platform for Reliable CAR-T Potency Assays ResourcesTechnical Data Sheet
Interested in designing custom cells? Contact Us
Product documentation
No frequently asked questions for this product yet.
